Facebook Twitter LinkedIn Google Plus RSS

Pharma and Life Sciences News

Biopharma company names former Rutgers professor to its management team

Biopharma company names former Rutgers professor to its management team

Bedminster-based biopharmaceutical company Matinas BioPharma Holdings Inc. has named a former Rutgers University professor as its new senior vice...

Vision Real Estate, Mill Creek Residential pair up to revamp Bayer campus in Montville

Vision Real Estate Partners has teamed with a well-known multifamily builder to redevelop a former Bayer HealthCare office park in Montville, where...

Cranbury biotech company buys N.C. biopharma firm focused on rare diseases

Cranbury-based biotech Amicus Therapeutics is paying $229 million for Scioderm Inc., a biopharmaceutical company focused on diseases with high unmet...

South Plainfield device maker creates Israeli unit

South Plainfield-based medical device maker Vention Medical said Monday it is opening a site in Israel near Tel Aviv to support the region's growing...

Valeant doubles office space in Bridgewater, to 620K sq. ft.

Valeant doubles office space in Bridgewater, to 620K sq. ft.

Valeant Pharmaceuticals International Inc. has leased another 310,000 square feet at Somerset Corporate Center in Bridgewater, doubling its footprint...

Big pharma still a force in Jersey's office market

Valeant’s HQ expansion latest move from sector

For a company that knows how to grab headlines, last week was no different for Valeant Pharmaceuticals International Inc.

Celgene wraps up $7.2B deal for Receptos

Celgene Corporation announced Thursday it has completed the previously announced acquisition of biopharmaceutical company Receptos Inc.

Generic topical maker buys Vineland building

IGI Laboratories Inc. is expanding its headquarters with the acquisition of a building in Vineland, according to real estate firm Wolf Commercial...

Valeant paying $1B for maker of first FDA-approved female sexual-dysfunction drug

Valeant paying $1B for maker of first FDA-approved female sexual-dysfunction drug

On Tuesday, Sprout Pharmaceuticals Inc. won approval for its female sexual-dysfunction drug, Addyi. On Thursday, the company got a new owner: Valeant...

NJBIZ Poll Question of the Week

Should sports betting be allowed in New Jersey? Vote View Results
close
Subscribe to Our Newsletters!
Click Here to Subscribe for Free Now!